Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
EXPRESSION OF WT1 AND CLAUDIN-5 IN ANGIOGENIC TUMORS S. Gobbo, A. Eccher, F. Comper, M. Brunelli, D. Segala, I. Cataldo, F. Menestrina, A. Scarpa, G. Martignoni 1Anatomia Patologica - Università di Verona Background Identification of endothelial cells is based on the expression of angioblastic linage-specific genes like CD31, CD34. WT1: protein is a zinc finger transcription factor expressed in endothelial progenitor cells that has been reported to be maintained during the differentiation. Claudin-5: key component of tight endothelial junctions. Methods Cases: 6 5 4 angiomas Kaposi’s sarcomas angiosarcomas Immunohistochemistry: WT1: anti-WT1, clone 6F-H2 from Dako diluted 1:100 Claudin-5: anti-claudin-5, clone 4C3C2 from Zymed diluted 1:100 ANGIOMA WT1 Claudin-5 KAPOSI SARCOMA WT1 Claudin-5 ANGIOSARCOMA WT1 Claudin-5 WT1 EXPRESSION ANGIOMA KAPOSI ANGIOSARCOMA Results: ANGIOMA WT1: claudin-5: consistent cytoplasmic and membranous immunoexpression expressed expecially on the luminal membrane with a week cytoplasmic labeling. KAPOSI WT1: claudin-5: strong cytoplasmic and membranous expression strong cytoplasmic and membranous expression ANGIOSARCOMA WT1: claudin-5: strong immunoexpression in only 2 of 4 (50%) expression in the cytoplasm and on the membrane Conclusions: WT1 and claudin-5 are specific endothelial markers and are manteined in angiomas and Kaposi’s sarcomas. Angiosarcomas mantein the expression of claudin-5 whereas WT1, that has been proven to behave as a tumor supressor protein, tends to be lost in the development of the neoplasm.